Silenseed LTD is a clinical stage biopharmaceutical company that is developing proprietary RNA interference (RNAi)-based cancer drugs and delivery systems designed to effectively penetrate and treat malignant solid tumors. The company' novel drugs, used together with the new delivery system, the LODER™ (LOcal Drug EluteR), have the potential to be one of the most highly effective treatments for solid tumor cancers. Diseases that currently are included in the company's pipeline are pancreatic cancer, prostate cancer and certain brain cancers.
| Website | http://www.silenseed.com |
| Revenue | $5 million |
| Employees | View employees |
| Founded | 1999 |
| Address | The Goldyne Savad Institute of Gene Therapy Hadassah Hebrew University Medical Center, Jerusalem, Jerusalem, IL |
| Phone | +972 2-674-3430 |
| Industry | Manufacturing General, Biopharma, Drug Discovery, Manufacturing, Biotechnology, Pharmaceuticals, Health Care, Science and Engineering, Therapeutics |
| Competitors | Novartis, Amgen, Biogen, Eisai Co., Ltd., CureVac, Editas Medicine, Sangamo Therapeutics, Inc., Alector, Akcea Therapeutics, Axovant Sciences Ltd +39 more (view full list) |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 3254 Companies, NAICS Code 325 Companies, NAICS Code 32541 Companies, NAICS Code 32 Companies |
Looking for a particular Silenseed LTD employee's phone or email?
Silenseed LTD Questions
The Silenseed LTD annual revenue was $5 million in 2026.
Silenseed LTD is based in Jerusalem, Jerusalem.
The NAICS codes for Silenseed LTD are [3254, 325, 32541, 32].
The SIC codes for Silenseed LTD are [283, 28].
Related Companies
